Brief: Mesoblast Posts Qtrly Loss After Tax $18.6 Mln
25/05/2023 23:30
May 26 (Reuters) - Mesoblast Ltd MSB.AX :
* QTRLY TOTAL REVENUE $1.9 MILLION VERSUS $2.0 MILLION
* QTRLY LOSS AFTER TAX $18.6 MILLION VERSUS LOSS $21.3
MILLION
Source text for Eikon: ID:nASX3njPrX
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil